SEC Comment Letter 0000000000-24-006386 to MUSTANG BIO, INC. (MBIO) (CIK 0001680048) (MBIO)
MUSTANG BIO, INC. (MBIO) (CIK 0001680048)
Date: June 4, 2024 · CIK: 0001680048 · Accession: 0000000000-24-006386
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279891
Letter
United States securities and exchange commission logo June 4, 2024 Manuel Litchman, M.D. President and Chief Executive Officer Mustang Bio, Inc. 377 Plantation Street Worcester, MA 01605 Re:Mustang Bio, Inc. Registration Statement on Form S-3 Filed May 31, 2024 File No. 333-279891 Dear Manuel Litchman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Joseph Walsh
Show Raw Text
United States securities and exchange commission logo
June 4, 2024
Manuel Litchman, M.D.
President and Chief Executive Officer
Mustang Bio, Inc.
377 Plantation Street
Worcester, MA 01605
Re:Mustang Bio, Inc.
Registration Statement on Form S-3
Filed May 31, 2024
File No. 333-279891
Dear Manuel Litchman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Joseph Walsh